Conference Reports for NaTaP

EASL - The International Liver Congress 2015 50th annual Meeting of the European association for the Study of the Liver Vienna, austria  april 22-26 Back

The Value of Survival Benefits from Treating Hepatitis C at Different Fibrosis Stages with All-Oral, Interferon-Free Therapy Relative to 'Watchful Waiting'       Reported by Jules Levin EASL 2015 April 22-26 Vienna Austria   S Johnson1, H PariseAL1, Y Sanchez Gonzalez2, A Wang2, S Virabhak1, T Juday2, S Saab3 1Medicus Economics Inc., 2AbbVie, Inc., 3Pfleger Liver Institute, UCLA